| Dr Casey George Curran, MD | |
|
1460 Ne Medical Center Dr, Bend, OR 97701-6061 | |
| (541) 382-6633 | |
| (541) 382-2719 |
| Full Name | Dr Casey George Curran |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 1460 Ne Medical Center Dr, Bend, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013276070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD192909 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Wallowa Memorial Hospital | Enterprise, OR | Hospital |
| Harney District Hospital | Burns, OR | Hospital |
| St Charles Prineville | Prineville, OR | Hospital |
| Blue Mountain Hospital | John day, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cascade Medical Imaging Llc | 9537140108 | 29 |
| Central Oregon Magnetic Resonance Imaging Llc | 8224058003 | 27 |
| Central Oregon Radiology Assoc Pc | 9335132091 | 35 |
| Lake Health District | 4284629221 | 18 |
| Morrow County Health District | 2365359296 | 43 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Morrow County Health District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770514481 PECOS PAC ID: 2365359296 Enrollment ID: O20040226001024 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Central Oregon Radiology Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590081 PECOS PAC ID: 9335132091 Enrollment ID: O20040407000799 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Lake Health District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376698522 PECOS PAC ID: 4284629221 Enrollment ID: O20040419000549 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Morrow County Health District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1376572099 PECOS PAC ID: 2365359296 Enrollment ID: O20061104000545 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Bend Memorial Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Cascade Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932621588 PECOS PAC ID: 9537140108 Enrollment ID: O20171009003041 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Entity Name | Central Oregon Magnetic Resonance Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114972155 PECOS PAC ID: 8224058003 Enrollment ID: O20171018001990 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Casey George Curran, MD 1460 Ne Medical Center Dr, Bend, OR 97701-6061 Ph: (541) 382-6633 | Dr Casey George Curran, MD 1460 Ne Medical Center Dr, Bend, OR 97701-6061 Ph: (541) 382-6633 |
News Archive
Demonstrating its dedication to close the loop for diabetes management, Medtronic, Inc. today announced that the first patient has been enrolled as part of the ASPIRE study of the MiniMed Paradigm x54 System featuring Low Glucose Suspend automation. Low Glucose Suspend works by automatically suspending insulin delivery temporarily if blood glucose levels become too low as defined by the patient and his or her healthcare provider and is a feature available commercially in Medtronic's Paradigm® Veo™ System in more than 35 countries outside of United States.
Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.
The Global Quality Foundation announced that Tahitian Noni International (TNI) Mexico is this year's winner of two Excelsis Awards - one for excellence in product quality, and the other for research and development. The Global Quality Foundation is a multifaceted organization that searches for improvements in quality processes, products and services that satisfy the needs of the current global society.
Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.
› Verified 8 days ago
Dr. Nicholas Song Boehling, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-5800 Fax: 541-706-6341 | |
Dr. Brant David Wommack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Ctr Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Richard Rotondi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2052 Ne 4th St, Bend, OR 97701 Phone: 541-280-2789 | |
Steven Dean Kjobech, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-2719 | |
Dr. David Krieves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 Fax: 541-382-9327 | |
Dr. Theodore Jennermann, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1460 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-6633 |